Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,367,926 papers from all fields of science
Search
Sign In
Create Free Account
FLT3LG protein, human
Known as:
FLT3-L
, Fms-Related Tyrosine Kinase 3 Ligand
, FMS-Related Tyrosine Kinase-3 Ligand
Expand
Fms-related tyrosine kinase 3 ligand (235 aa, ~26 kDa) is encoded by the human FLT3LG gene. This protein is involved in the positive regulation of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Bone Marrow
Cytokine Gene
Cytokine Receptor Binding
Cytokine Signaling
Expand
Broader (1)
FLT3 ligand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Optimisation du ciblage de l'antigène CD138 sur des modèles murins et canins pour la radioimmunothérapie (RIT) du cancer du sein et évaluation de l'intérêt d'une immunomodulation par le Flt3-L en…
Maya Diab
2015
Corpus ID: 171342254
La radioimmunotherapie (RIT) consiste a injecter aux patients des anticorps monoclonaux (AcM) radiomarques specifiques d…
Expand
2015
2015
In vitro studies on human hematopoiesis
S. Vanhee
2015
Corpus ID: 87786488
During recent years, the phenotype and function of innate lymphoid cells has been unraveled both in the murine as in the human…
Expand
2012
2012
Differentiation factor Fms-like tyrosine kinase 3 ligand is a modulator of cell responses in autoimmune diseases
M. Dehlin
2012
Corpus ID: 55822896
Fms-like tyrosine kinase 3 (Flt3) is a receptor on common stem cell progenitors and has a crucial role in haematopoiesis…
Expand
2010
2010
RAPID COMMUNICATIONS STRIKING AUGMENTATION OF HEMATOPOIETIC CELL CHIMERISM IN NONCYTOABLATED ALLOGENEIC BONE MARROW RECIPIENTS BY FLT 3 LIGAND AND TACROLIMUS
Anand
,
lYENGAR
,
+6 authors
A. Thomson
2010
Corpus ID: 5484274
The influence of granulocyte-macrophage colonystimulating factor (GM-CSF) and the recently identified hematopoietic stem…
Expand
2002
2002
Ex vivo expansion of human umbilical cord blood hematopoietic stem and progenitor cells
N. Kusadasi
2002
Corpus ID: 82450314
textabstractThe goal of this thesis research is to establish ex vivo expansion conditions for HSCs derived from UCB. To realize…
Expand
2002
2002
The FLT 3 Ligand Is a Direct and Potent Stimulator of the Growth of Primitive and Committed Human CD 34 ' Bone Marrow Progenitor Cells In Vitro
L. Rusten
,
S. Lyman
,
Ole
,
Veiby
,
S. Jacobsen
2002
Corpus ID: 8571693
The present studies investigated the effects of the recently cloned flt3 ligand (FL) on the in vitro growth and differentiation…
Expand
2000
2000
Advances in Brief Flt 3-Ligand Induces Transient Tumor Regression in an Ectopic Treatment Model of Major Histocompatibility Complex-negative Prostate Cancer 1
R. Ciavarra
,
K. Somers
,
+4 authors
P. Schellhammer
2000
Corpus ID: 20892810
We assessed the in vivo efficacy of Flt3-ligand (Flt3-L) treatment in C57BL/6 mice bearing a well-established MHC class I…
Expand
2000
2000
Serum-free culture conditions for the generation of dendritic cells from cord blood CD34+ hematopoietic progenitors: phenotypic and functional analysis.
E. Doménech
,
E. Villén
,
E. González-Barca
,
S. Querol
,
J. García
,
F. Rueda
Haematologica
2000
Corpus ID: 450348
Increasing pre-clinical and clinical data suggest the efficiency of dendritic cells (DCs) in cancer immunotherapy. Relapse after…
Expand
1998
1998
Expansion of cord blood progenitor cells.
S. Querol
,
G. Capmany
,
J. Cancelas
,
Jorge M. Garcia
Bone Marrow Transplantation
1998
Corpus ID: 38393994
Cord blood (CB) provides an alternative source of stem cells for transplantation, although in a considerable number of cases CB…
Expand
1998
1998
FLT3-L ENHANCES THE EARLY STEM CELL COMPARTMENT AFTER EX VIVO AMOLIFICATION OF CORD BLOOD CD34+ CELLS
L. Felice
,
T. Pucchio
,
+8 authors
W. Arcese
1998
Corpus ID: 87121861
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE